Stillman Jordan, Martin Alicia, Miguez Maria-Jose, McDaniel H Reginald, Konefal Janet, Woolger Judi M, Lewis John E
Department of Psychiatry and Behavioral Sciences, Miami, Florida.
Department of School of Integrated Science and Humanity, Florida International University, Miami, Florida.
J Clin Transl Res. 2020 Jan 29;5(2):68-75.
The objective of the present study was to investigate the relationships among pro-brain-derived neurotrophic factor (BDNF) and mature BDNF and immune functioning during aloe polymannose multinutrient complex (APMC) treatment in persons with moderate to severe Alzheimer's dementia (AD).
An open-label trial of 12 months was used to execute the study. Thirty-four adults with AD were enrolled and consumed four teaspoons/day of APMC for 12 months. Subjects were assessed at baseline and 12 months follow-up for proBDNF and BDNF and cytokines, growth factors, T-cell and B-cell subsets, and complete blood count to measure immune functioning. All biomarkers were intercorrelated.
Several relationships were identified between proBDNF, BDNF, and BDNF/proBDNF ratio and immune function at 12 months, particularly BDNF with vascular endothelial growth factor (VEGF) (=0.55, =0.03), epidermal growth factor (EGF) (=0.74, =0.001), and CD95+CD3+ (%) (=-0.64, =0.03) and proBDNF with VEGF (=0.64, =0.02), EGF (=0.86, <0.001), and CD16+56+ (%) (=-0.78, <0.01). Other correlations were noted for various immune function variables with BDNF, proBDNF, and/or BDNF/proBDNF ratio at baseline and 12 months. Dichotomizing subjects on BDNF above and below 5000 pg/mL revealed additional relationships with platelets and neutrophils.
The associations between BDNF and proBDNF and various immune markers, such as VEGF, EGF, and CD95+CD3+ ratio, provide insight into the link between neurological function and the immune system. These relationships were even stronger in response to APMC treatment, which lends support to previous findings showing improved immune function after dietary supplementation.
AD patients have conventional treatment options with limited efficacy for counteracting the deleterious effects of the disease on neurological function. The link between neurological and immune function has been understudied in this population. Overall, our results showed a significant beneficial relationship between immune and neurological function, particularly in response to 12 months of treatment with an all-natural polysaccharide-based dietary supplement that is a known immunomodulator. Thus, the use of this dietary supplement may benefit these patients by simultaneously improving immune and neurological function.
本研究的目的是调查中度至重度阿尔茨海默病(AD)患者在接受芦荟多聚甘露糖复合营养素(APMC)治疗期间,前脑源性神经营养因子(pro-BDNF)、成熟脑源性神经营养因子(BDNF)与免疫功能之间的关系。
采用一项为期12个月的开放标签试验进行本研究。招募了34名AD成年患者,每天服用4茶匙APMC,持续12个月。在基线期和随访12个月时对受试者进行评估,检测proBDNF、BDNF、细胞因子、生长因子、T细胞和B细胞亚群以及全血细胞计数,以测量免疫功能。所有生物标志物之间均相互关联。
在12个月时,发现proBDNF、BDNF以及BDNF/proBDNF比值与免疫功能之间存在多种关系,特别是BDNF与血管内皮生长因子(VEGF)(r = 0.55,P = 0.03)、表皮生长因子(EGF)(r = 0.74,P = 0.001)以及CD95+CD3+(%)(r = -0.64,P = 0.03)相关,proBDNF与VEGF(r = 0.64,P = 0.02)、EGF(r = 0.86,P < 0.001)以及CD16+56+(%)(r = -0.78,P < 0.01)相关。在基线期和12个月时,还注意到各种免疫功能变量与BDNF、proBDNF和/或BDNF/proBDNF比值之间的其他相关性。将受试者按BDNF高于和低于5000 pg/mL进行二分法分析,发现与血小板和中性粒细胞存在其他关系。
BDNF和proBDNF与各种免疫标志物(如VEGF、EGF和CD95+CD3+比值)之间的关联,为神经功能与免疫系统之间的联系提供了见解。这些关系在APMC治疗反应中更为明显,这支持了先前关于饮食补充后免疫功能改善的研究结果。
AD患者的传统治疗方案在对抗该疾病对神经功能的有害影响方面疗效有限。该人群中神经功能与免疫功能之间的联系尚未得到充分研究。总体而言,我们的结果表明免疫功能与神经功能之间存在显著的有益关系,特别是在接受一种已知具有免疫调节作用的全天然多糖类饮食补充剂治疗12个月后。因此,使用这种饮食补充剂可能通过同时改善免疫和神经功能而使这些患者受益。